AI-enabled Cell Culture
Media Development Platform
Catalog Culture Media Culture Media Optimization
Introduction
The AlfaMedX platform applies artificial intelligence (Al) technology to the development of cell culture media formulations, establishing a media formulation algorithm platform to develop media suitable for cell growth, protein expression, and cell differentiation. The platform has a stable culture medium supply capacity with an annual output of 250,000 L. It has passed ISO9001:2015 certification and continues to supply high quality culture medium for the research and development and production of customers in the global life science field.
Advantages
AI Algorithm Empowerment
End-to-end AI integration across formulation design, data analytics, and intelligent recommendation.
Large-Scale Database
A 10,000+ formulation database covering diverse cell lines, including basal and feed formulations across multiple cell types.
Short Development Cycle
Customized formulations developed in just 1–2 months, delivering speed with consistent quality.
Case Study
Using an AI-generated library of 50 media formulations, 64%–74% of tested formulations demonstrated superior VCD or titer performance compared with a commercial control.
Across all tested cell lines, at least one formulation was identified for each cell line that outperformed the commercial control in either VCD or titer.
Some formulas are suitable for 50% of test cell lines and outperform commercial media in specific cell lines.
Apply for trial
It helps you experience first before making a decision,
and easily start your trial application.
It helps you experience first before making a decision, and easily start your trial application.
